Display Settings:

Format
Items per page

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 23

1.

Influenza

An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. [from MeSH]

MedGen UID:
9466
Concept ID:
C0021400
Disease or Syndrome
2.

Vaccines

Preparations containing substances with antigenic properties administered to activate the immune system, thereby inducing an immune response. Vaccines range from inactivated or attenuated microorganisms (bacteria and viruses), enhanced autologous tumor cells, tumor antigens or epitopes that are used to elicit host immune responses. Vaccines are used for the prevention, amelioration, or treatment of infectious diseases and cancer. [from NCI]

MedGen UID:
52963
Concept ID:
C0042210
Pharmacologic Substance
3.

Infection

Unknown contamination with disease-producing germs. [from HHCC]

MedGen UID:
43874
Concept ID:
C0021311
Disease or Syndrome
4.

Vaccinated (qualifier)

Treated with a vaccine. [from NCI]

MedGen UID:
274370
Concept ID:
C1519885
Finding
5.

Inhibition

MedGen UID:
5809
Concept ID:
C0021469
Molecular Function
6.

Endoglycosidases

MedGen UID:
760845
Concept ID:
C3537242
Pharmacologic Substance
7.

FluMist

MedGen UID:
270365
Concept ID:
C1311943
Pharmacologic Substance
8.

barbituric acid salt

A drug used to treat insomnia, seizures, and convulsions, and to relieve anxiety and tension before surgery. It belongs to the family of drugs called central nervous system (CNS) depressants. [from NCI]

MedGen UID:
67405
Concept ID:
C0220791
Pharmacologic Substance
9.

Viral disease

disease produced by viruses. [from CRISP]

MedGen UID:
53027
Concept ID:
C0042769
Disease or Syndrome
10.

Immunoglobulins

there are two types of polypeptide chains responsible for the biological and immunological properties of the different immunoglobulins, the heavy chain and the light chain; they are linked by covalent and non-covalent forces to give a four-chain Y-shaped structure based on pairs of identical heavy and light chains; each chain consists of a variable region and a constant region which are coded for by different genes; some immunoglobulin classes occur as polymers of this basic monomer. [from CRISP]

MedGen UID:
43841
Concept ID:
C0021027
Pharmacologic Substance
11.

Viral vaccine

Any vaccine preparation composed of a live, attenuated, inactivated, killed or recombinant virus. Administration of a viral vaccine is to provide prophylaxis against viral disease or used as a vehicle to treat cancers. [from NCI]

MedGen UID:
22655
Concept ID:
C0042742
Pharmacologic Substance
12.

Respiratory Tract Diseases

MedGen UID:
19750
Concept ID:
C0035242
Disease or Syndrome
13.

Disease due to Orthomyxoviridae

Virus diseases caused by the ORTHOMYXOVIRIDAE. [from MeSH]

MedGen UID:
18204
Concept ID:
C0029342
Disease or Syndrome
14.

Barbiturates

family of 2,4,6-triketopyrimidines with various hydrocarbon side groups at C5; CNS depressants used as anticonvulsants, sedatives, hynotics, and anesthetics; commonly abused and highly addictive. [from CRISP]

MedGen UID:
14028
Concept ID:
C0004745
Pharmacologic Substance
15.

RNA Virus Infections

MedGen UID:
11250
Concept ID:
C0035690
Disease or Syndrome
16.

Respiratory tract infection

Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. [from MeSH]

MedGen UID:
11199
Concept ID:
C0035243
Disease or Syndrome
17.

Endoglycosidase [EPC]

MedGen UID:
8617
Concept ID:
C0014162
Pharmacologic Substance
18.

Influenza virus vaccine

Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed or attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The vaccine is usually bivalent or trivalent, containing one or two INFLUENZAVIRUS A strains and one INFLUENZAVIRUS B strain. [from MeSH]

MedGen UID:
7073
Concept ID:
C0021403
Pharmacologic Substance
19.

Glycosidase

covering the sugar hydrolases. [from CRISP]

MedGen UID:
5349
Concept ID:
C0017976
Pharmacologic Substance
20.

Biological Products

Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay. They are used especially in diagnosis and treatment of disease (as vaccines or pollen extracts). Biological products are differentiated from BIOLOGICAL FACTORS in that the latter are compounds with biological or physiological activity made by living organisms. (From Webster's 3d ed) [from MeSH]

MedGen UID:
577
Concept ID:
C0005522
Pharmacologic Substance

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...